ChemTrak Inc. said that it has licensed worldwide, non-exclusive rights to technology from nine Syva Co. patents inexchange for a licensing fee and future royalties.

The patents cover technology related to development of assaysusing solid support chemistry, which permits development ofself-contained test products, according to ChemTrak(NASDAQ:CMTR) of Sunnyvale, Calif.

The current agreement amends an earlier licensing agreementunder which Syva, the diagnostic subsidiary of Syntex Corp.,licensed patents covering ChemTrak's AccuMeter cholesteroltest.

(c) 1997 American Health Consultants. All rights reserved.

No Comments